40 completed, 18 unknown, 7 recruiting, 5 withdrawn. 27 Not applicable, 8 Phase 4, 5 Phase 1, 5 Phase 2, 4 Phase 3.
Follow Adverse Drug Event: new trials by email Literature Review of Adverse Drug Event trials Research Report on Adverse Drug Event
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| MEOP - Multidimensional Evaluations in Oncological Psychiatry Psychiatric and neuropsychological evaluation through rating scales - Psychiatric Disorder, Cognition Disorder | Not yet recruiting | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 2000 | 2026-01-30 | 2026-02-12 | |
| Efficacy and Safety of Remimazolam Besylate for Sedation in Post-Non-Cardiac Surgery Patients Requiring Mechanical Ventilation Remimazolam Besylate, Dexmedetomidine Hydrochloride - Effect of Drug, Adverse Drug Event | Phase 4 | Recruiting | Beijing Shijitan Hospital, Capital Medical University | 306 | 2025-01-20 | 2026-06-16 |
| Active Pharmacovigilance Study of the Medicine Rinvoq™ (Upadacitinib) Upadacitinib - Inflammatory Disease, Drug Side Effect | Unknown | Universidade do Porto | 150 | 2024-07-01 | 2024-07-15 | |
| Comparative Study of Tranexamic Acid Dosing in Cardiac Surgery Tranexamic acid at a dose of 10 mg/kg followed by 1 mg/kg/h, Tranexamic acid at a dose of 20 mg/kg, Tranexamic acid at a dose of 30 mg/kg - Blood Coagulation Disorder, Postoperative Blood Loss | Not applicable | Recruiting | University of Ioannina | 150 | 2024-05-14 | 2025-09-10 |
| Collaborative Nurse-pharmacist Counseling for Self-administered Biologics Collaborative nurse-pharmacist counseling - Medication Adherence, Medication Nonadherence | Not applicable | Withdrawn | Tonia Carr | 2024-03-01 | 2024-04-29 | |
| QSPainRelief-STRAT Opioid drug + CNS-acting add-on drug - Chronic Pain, Analgesia | Not applicable | Unknown | Université Catholique de Louvain | 150 | 2024-02-01 | 2024-02-06 |
| A Study of GC101 TIL in Advanced Melanoma (BZ) GC101 TIL - Tumor Infiltrating Lymphocytes, Safety | Phase 1 / Phase 2 | Completed | Shanghai Juncell Therapeutics | 18 | 2023-11-08 | 2025-12-23 |
| Effect of Salovum™ and SPC-Flakes™ on Abemaciclib-induced Gastrointestinal Toxicity in Early Breast Cancer SPC-flakes, Salovum, Placebo - Early-stage Breast Cancer, Diarrhea | Phase 3 | Unknown | Henrik Lindman | 100 | 2023-06-07 | 2023-11-30 |
| Melatonin for Prevention of Kidney Injury Melatonin, Placebo Capsule - Acute Kidney Injury, Adverse Drug Event | Phase 3 | Recruiting | Rutgers, The State University of New Jersey | 300 | 2023-06-05 | 2025-12-17 |
| Oliceridine in Patients With Acute Burn Injuries Oliceridine, Historical opioid use - Acute Pain, Burns | Phase 4 | Completed | University of Tennessee | 31 | 2023-04-01 | 2023-10-26 |
| Oncolytic Virus Ad-TD-nsIL12 for Progressive Pediatric Diffuse Intrinsic Pontine Glioma Ad-TD-nsIL12 - Oncolytic Virus, Diffuse Intrinsic Pontine Glioma | Phase 1 | Recruiting | Capital Medical University | 18 | 2023-01-04 | 2024-02-28 |
| Oncolytic Virus Ad-TD-nsIL12 for Primary Pediatric Diffuse Intrinsic Pontine Glioma Ad-TD-nsIL12 - Oncolytic Virus, Diffuse Intrinsic Pontine Glioma | Phase 1 | Recruiting | Capital Medical University | 18 | 2023-01-04 | 2024-02-28 |
| Pharmacogenomic Association Study in Indian Children With Acute Lymphoblastic Leukemia ALL, Childhood, Pediatric Cancer | Recruiting | University of Geneva, Switzerland | 556 | 2022-12-01 | 2026-01-15 | |
| NUDGE-EHR Replication Trial at Mass General Brigham Follow-up booster Alert, Pre-commitment, Enhanced Alert - Aging, Benzodiazepine Sedative Adverse Reaction | Not applicable | Completed | Brigham and Women's Hospital | 201 | 2022-11-10 | 2025-05-21 |
| A Phase I Study of GC101 TIL in Advanced Solid Tumors TIL therapy - Tumor Infiltrating Lymphocytes, Safety | Phase 1 | Completed | Shanghai Juncell Therapeutics | 43 | 2022-10-12 | 2025-12-10 |
| Peppermint Oil for the Treatment of Irritable Bowel Syndrome or Functional Abdominal Pain in Children: the MINT Study Small intestinal release peppermint oil, Peppermint sweets, Placebo - Irritable Bowel Syndrome, Functional Abdominal Pain Syndrome | Phase 3 | Completed | St. Antonius Hospital | 228 | 2022-05-12 | 2025-05-30 |
| Impact of a Pharmacovigilance Program Led by Advanced Practice Nursing Pharmacovigilance Program - Adverse Drug Event | Not applicable | Completed | Natalia Rodriguez Galan | 395 | 2022-05-01 | 2024-10-18 |
| Safety of Pediatric COVID-19 Vaccination Observational - Pain, Injection Site Reaction | Completed | Duke University | 299 | 2022-04-06 | 2026-07-01 | |
| Simultaneous mRNA COVID-19 and IIV4 Vaccination Study mRNA COVID-19, IIV4, Placebo (saline) - Quality of Life, Injection Site Reaction | Phase 4 | Completed | Duke University | 348 | 2021-10-04 | 2024-03-19 |
| Simultaneous RZV and aIIV4 Vaccination FLUAD® Quadrivalent, Fluzone® High-Dose Quadrivalent, SHINGRIX® - Pain, Quality of Life | Phase 4 | Completed | Duke University | 267 | 2021-09-21 | 2024-07-11 |
Showing 20 of 73. Sign in to see all of them.
Drug-Related Side Effects and Adverse Reactions (73) · COVID-19 (4) · Influenza, Human (4) · Injection Site Reaction (4) · Pain (4) · Breast Neoplasms (3) · Medication Adherence (3) · Anaphylaxis (2) · Diffuse Intrinsic Pontine Glioma (2) · Esophageal Neoplasms (2) · Melanoma (2) · Neoplasms (2) · Patient Compliance (2) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (2) · Acute Kidney Injury (1)
Chemically-Induced Disorders (73) · Pathological Conditions, Signs and Symptoms (16) · Pathologic Processes (13) · Infections (11) · Neoplasms (11) · Neoplasms by Site (10) · Respiratory Tract Diseases (9) · Immune System Diseases (8) · RNA Virus Infections (8) · Signs and Symptoms (8) · Virus Diseases (8) · Neoplasms by Histologic Type (7) · Respiratory Tract Infections (7) · Neurologic Manifestations (6) · Skin Diseases (6)
Drug Therapy (2) · Influenza Vaccines (2) · Medical Order Entry Systems (2) · Medication Reconciliation (2) · ((3-methoxythiophen-2-yl)methyl)((2-(9-(pyridin-2-yl)-6-oxaspiro(4.5)decan-9-yl)ethyl))amine (1) · 2019-nCoV Vaccine mRNA-1273 (1) · Atropine (1) · BNT162 Vaccine (1) · Capecitabine (1) · Cisplatin (1) · Cyclopentolate (1) · Deprescriptions (1) · Dexmedetomidine (1) · Dihydrouracil Dehydrogenase (NADP) (1) · Docetaxel (1)
Duke University (4) · Brigham and Women's Hospital (3) · Tabula Rasa HealthCare (3) · Capital Medical University (2) · Groupe Hospitalier Pitie-Salpetriere (2) · Johns Hopkins University (2) · McGill University Health Centre/Research Institute of the McGill University Health Centre (2) · Shanghai Juncell Therapeutics (2) · University Hospital, Montpellier (2) · University of British Columbia (2) · Zhong Wang (2) · Assistance Publique - Hôpitaux de Paris (1) · Beijing Shijitan Hospital, Capital Medical University (1) · Centre for Innovation and Research in Aging, Canada (1) · Children's Hospital of Eastern Ontario (1)
United States (21) · China (11) · France (7) · Canada (5) · Netherlands (3) · Denmark (2) · Finland (2) · Germany (2) · Italy (2) · Spain (2) · Sweden (2) · Brazil (1) · Ecuador (1) · Egypt (1) · Greece (1)
Corinne M Hohl, MD, MSc (2) · Hongwei Zhang, Prof. (2) · Kenneth Schmader, MD (2) · Veronique Michaud, PhD (2) · Zhong Wang, M.D. (2) · Amy Plint, MD, MSc (1) · Angela YJ Tan, MMed (1) · Arine Vlieger, MD, PhD (1) · Ayse Gurses (1) · Carole Goodine, Pharm D (1) · David W Bates, MD MSc (1)
PMID 33546752, PMID 19223865, PMID 21270794, PMID 22111914, PMID 23827895, PMID 23962279, PMID 23965840, PMID 24896594, PMID 25475246, PMID 25624441, PMID 25649903, PMID 27824625, PMID 27860104, PMID 28418992, PMID 28692533, PMID 28825943, PMID 29123084, PMID 29255735, PMID 29295436, PMID 30037297, PMID 30559228, PMID 30572894, PMID 31272427, PMID 31476877, PMID 31647032, PMID 32175969, PMID 32481505, PMID 33182528, PMID 33201236, PMID 33234662, PMID 33413494, PMID 33443580, PMID 33455928, PMID 33832998, PMID 33866662, PMID 33997903, PMID 34041617, PMID 34053407, PMID 34362410, PMID 34503908, PMID 34597411, PMID 34727956, PMID 35040926, PMID 35114404, PMID 35199262, PMID 36307826, PMID 36712813, PMID 37124199, PMID 37393237, PMID 37645440
R21AG057396 (1), R33AG057388 (1)